INTRINSICALLY MAGNETIC HYDROXYAPATITE

The present invention relates to hydroxyapatite doped with Fe2+ ions and Fe3+ ions which partially substitute the calcium ions in the crystal lattice. The hydroxyapatite is characterized by an intrinsic magnetism of 0.05 to 8 emu/g, measured by applying a magnetic field of 34 Oe, due to the presence...

Full description

Saved in:
Bibliographic Details
Main Authors LANDI, ELENA, SANDRI, MONICA, RIVAS REY, JOSE, PRESSATO, DANIELE, BANOBRE LOPEZ, MANUEL, TAMPIERI, ANNA, MARCACCI, MAURILIO
Format Patent
LanguageEnglish
French
German
Published 05.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to hydroxyapatite doped with Fe2+ ions and Fe3+ ions which partially substitute the calcium ions in the crystal lattice. The hydroxyapatite is characterized by an intrinsic magnetism of 0.05 to 8 emu/g, measured by applying a magnetic field of 34 Oe, due to the presence of magnetic nano-domains in the crystal lattice of HA, given the limited amount of magnetic secondary phases present, less than about 3% by volume. The intrinsically magnetic hydroxyapatite can be loaded with biological substances selected in the group consisting of proteins, genes, stem cells, growth factors, vascularization factors, active substances and drugs, under the control of an external magnetic field, as a carrier and release agent for biological substances or drugs, as a contrast agent in diagnostics or for bone or osteocartilage regeneration.
Bibliography:Application Number: EP20110752344